John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 53,835 shares at $74.90 ($4.0M) on 2015-09-24, disclosed to the SEC on 2015-09-24.
Open-market sale of $4.0M KYTH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.90 | 13,272 | $994K | 24.7% |
| 2 | $74.90 | 13,646 | $1.0M | 25.3% |
| 3 | $74.90 | 13,154 | $985K | 24.4% |
| 4 | $74.90 | 13,763 | $1.0M | 25.6% |
| Total | $74.90 avg | 53,835 | $4.0M | 100% |
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |